Legislative Update: Wins and Losses as First House Deadline Approaches

The end of April marks the deadline for policy committees to hear all legislation identified as having a fiscal impact on the state (which includes most bills). If bills are not heard by then, they are automatically turned into two-year bills and are stuck in their existing location until next year. With the Legislature forced […]

How Can I Invest in a Mushroom Company?

Written by: Hugh Mayo, J.D. Candidate 2021 In 2018, the FDA made waves when, for the first time, they issued a “Breakthrough Therapy” designation to fast track the development of a psilocybin-based therapy for treatment-resistant depression.1 Psilocybin and psilocin—the principle psychedelic compounds found in mushrooms—are both Schedule I compounds under the Controlled Substances Act making them federally […]

The Decriminalization of Magic Mushrooms

Written by Kristen Abajian Welcome to a murky new movement to bring psychedelics out of the shadows and into a medical and research forefront. This movement aims to decriminalize psilocybin, otherwise known as the “magic” in magic mushrooms. What is psilocybin?  Psilocybin is the main ingredient found in several species of psychoactive mushrooms. The most […]